Synthesis and In Vitro Anti Leishmania amazonensis Biological Screening of Morita-Baylis-Hillman Adducts Prepared from Eugenol, Thymol and Carvacrol

Leishmaniasis represents a series of severe neglected tropical diseases caused by protozoa of the genus Leishmania and is widely distributed around the world. Here, we present the syntheses of Morita-Baylis-Hillman adducts (MBHAs) prepared from eugenol, thymol and carvacrol, and their bioevaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Xavier, Francisco José Seixas, Rodrigues, Klinger Antonio da Franca, de Oliveira, Ramon Guerra, Lima Junior, Claudio Gabriel, Rocha, Juliana da Câmara, Keesen, Tatjana Souza Lima, de Oliveira, Marcia Rosa, Silva, Fábio Pedrosa Lins, Vasconcellos, Mário Luiz Araújo de Almeida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274563/
https://www.ncbi.nlm.nih.gov/pubmed/27834831
http://dx.doi.org/10.3390/molecules21111483
Descripción
Sumario:Leishmaniasis represents a series of severe neglected tropical diseases caused by protozoa of the genus Leishmania and is widely distributed around the world. Here, we present the syntheses of Morita-Baylis-Hillman adducts (MBHAs) prepared from eugenol, thymol and carvacrol, and their bioevaluation against promastigotes of Leishmania amazonensis. The new MBHAs are prepared in two steps from essential oils in moderate to good yields and present IC(50) values in the range of 22.30–4.71 μM. Moreover, the selectivity index to the most potent compound is very high (SIrb > 84.92), far better than that of Glucantime(®) (SIrb 1.39) and amphotericin B (SIrb = 22.34). Conformational analysis were carried out at the M062X//6-31+G(d,p) level of theory to corroborate a hypothesis about the nitroaromatic bioreduction mechanism.

Ejemplares similares